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Abstract
Background: Aortic root diameter is a clinically relevant trait due to its known relationship with the pathogenesis
of aortic regurgitation and risk for aortic dissection. African Americans are an understudied population despite a
particularly high burden of cardiovascular diseases. We report a genome-wide association study on aortic root
diameter among African Americans enrolled in the HyperGEN study. We invoked a two-stage, mixed model
procedure to jointly identify SNP allele and copy number variation effects.
Results: Results suggest novel genetic contributors along a large region between the CRCP and KCTD7 genes on
chromosome 7 (p = 4.26 × 10
-7); and the SIRPA and PDYN genes on chromosome 20 (p = 3.28 × 10
-8).
Conclusions: The regions we discovered are candidates for future studies on cardiovascular outcomes, particularly
in African Americans. The methods we employed can also provide an outline for genetic researchers interested in
jointly testing SNP and CNV effects and/or applying mixed model procedures on a genome-wide scale.
Background
African Americans are known to be at increased risk for
adverse cardiovascular outcomes including arterial stiff-
ness and hypertension [1,2]. This observation makes Afri-
can Americans a favorable population for genome-wide
association studies (GWAS) on traits related to cardio-
vascular disease. The size of the aortic root is one such
trait as it has been shown to play a major role in the
pathogenesis of aortic regurgitation and risk for aortic
dissection [3]. Enlargement of the aortic root has also
been shown to be associated with arterial blood pressure
in some studies [4-8] but not others [9] leading some
investigators to hypothesize its role in the development
of hypertension [10,11]. Despite reports of high heritabil-
ity in common cardiovascular diseases, even large-scale
GWAS have failed to replicate positive associations
[12-14]. One possible explanation is that these complex
diseases may be mediated by multiple pathophysiologic
processes, such as enlargement of the aortic root, which
are potentially better suited for disease-gene association
testing. Previous studies have reported linkage between
the diameter of the aortic root and candidate genes by
using an extreme-values approach [15]; and in a genome
scan [16]. A meta-analysis of GWAS results has identified
genetic variants associated with the trait on chromo-
somes 5, 12p, 12q, and 17 [17]. However, only individuals
of European ancestry were included.
The success of GWAS relies on the assumption that
the heritability in common diseases can be captured by
relatively few common genetic variants in the form of
single nucleotide polymorphisms (SNPs) - sometimes
referred to as the common disease, common variant
hypothesis [18,19]. However, a substantial proportion of
the heritability of many of these diseases remains left
unexplained as traditional GWAS based upon SNPs
have only accounted for a modest proportion of the
total genetic variation. Among others, copy number var-
iation (CNV) has been cited as a potential source of this
so-called missing heritability [20].
Two recent studies have investigated the genomic
architecture of CNVs in African Americans [21,22].
These reports suggest CNVs represent a significant
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the results from a non-traditional GWAS on aortic root
diameter in African Americans which evaluated SNP and
copy number effects simultaneously. We gathered pheno-
typic and genetic data on 1,086 family members enrolled
in the HyperGEN study [23] who were genotyped on the
Affymetrix 6.0 array. We obtained SNP and CNV calls
from the Larry Bird application in Birdsuite software
[24]; and performed a two-stage, mixed model procedure
designed to identify SNP and CNV effects after control-
ling for potential confounders. We found two interesting
signals: one stretching between the CRCP and KCTD7
genes on chromosome 7 and the other between the
SIRPA and PDYN genes on chromosome 20.
Methods
Phenotypic data was obtained on 1,086 self-reported Afri-
can American family members and individuals enrolled in
the HyperGEN study [23]. HyperGEN is one of four
Family Blood Pressure Program networks supported by
the National Heart, Lung, and Blood Institute (NHLBI) to
identify genetic contributors to hypertension. Subjects
were recruited from centers located in Birmingham, AL
and Forsyth County, NC. In the first recruitment phase of
the HyperGEN study, hypertensive sibships eligible for
recruitment consisted of probands with onset of hyperten-
sion by age 60 and one or more hypertensive siblings who
were willing to participate in the study. In the second
phase, the offspring of the hypertensive siblings were
recruited. Hypertension was defined as an average systolic
blood pressure ≥ 140 mm Hg or an average diastolic blood
pressure ≥ 90 mm Hg during at least two evaluations, or
receiving medical treatment for hypertension.
The present study cohort consisted of 421 families.
Families varied in size from single individuals to larger
families, up to 10 (Table 1). Measurements were recorded
on age, gender, height, weight, body mass index, systolic
blood pressure, diastolic blood pressure, and aortic root
diameter (Table 2). Aortic root diameter measurements
were performed during quiet respiration with two-
dimensional echocardiography. Aortic root was evaluated
at end-diastole at the level of the aortic annulus and the
sinuses of Valsalva in the long-axis view [25]. Measure-
ments were made at Cornell Medical Center and verified
by an experienced investigator. Further procedures for
evaluating aortic root dimensions at the sinuses of Val-
salva are described in Roman et al. [26,27]. This study
was approved by the Institutional Review Board (IRB)
and all subjects provided informed consent.
Genotyping procedures
Genetic data was obtained through the Affymetrix Gen-
ome-Wide Human SNP Array 6.0. Samples were
grouped into 34 batches in which a batch consisted of
all the samples that were processed on a particular day.
The Affymetrix genotyping protocol was followed. Qual-
ity control was assessed using fifty control SNPs located
on each array which were typed using a second indepen-
dent platform (ABI Taqman). Genotype-based quality
control was assessed by checking markers for Mendelian
inconsistencies, potential patterns of missing data, and
allele frequency measurements (Additional file 1, S1).
SNPs and CNVs were called using Birdsuite software,
Version 1.5.5 [24]. Software parameters were kept at the
developers’ default values; and the Human Genome 18
reference build was used for probe localization. Samples
were processed by batch to eliminate batch effects. This
allows for better clustering of the data and improves
sensitivity and specificity of the algorithm compared to
combining data across batches [28]. The Larry Bird
application within Birdsuite was used to generate CNV-
SNP genotypes at each locus. Larry Bird combines infor-
mation on copy number segment calls using the HMM-
Table 1 Family structure of African American study
participants enrolled in HyperGEN and genotyped on the
Affymetrix 6.0 array
Family size Families Individuals
19 9 9 9
2 160 320
3 69 207
4 48 192
5 23 115
61 0 6 0
78 5 6
800
93 2 7
10 1 10
Total 421 1,086
Table 2 Descriptive statistics of African American study
participants enrolled in HyperGEN and genotyped on the
Affymetrix 6.0 array
n = 1,086
Age (years) 43.9 ± 13.4
Females (%) 66.6
Height (cm) 168.0 ± 90.0
Weight (kg) 91.3 ± 23.9
BMI (kg/m
2) 32.5 ± 8.1
SBP (mmHg) 128.9 ± 22.2
DBP (mmHg) 73.8 ± 11.7
Center
Birmingham, AL 856
Forsyth County, NC 230
ARD (cm) 3.26 ± 0.38
Mean ± standard deviation when applicable. BMI, body mass index; SBP,
systolic blood pressure; DPB, diastolic blood pressure; ARD, aortic root
diameter.
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cations within Birdsuite. The result is a more accurate
depiction of locus-specific nucleotide frequency, particu-
larly in non-diploid regions; and allows for the joint
modeling of allelic and copy number effects at a given
locus. Only calls with confidence values less than 0.1
were considered per the developers’ recommendation
(higher values indicate more uncertainty).
Statistical analyses
SNP and CNV joint tests of genetic association on the
logarithm of aortic root diameter (AR2D) were con-
ducted on all autosomal SNP marker loci genotyped on
the Affymetrix 6.0 array that passed quality control
thresholds (Additional file 1, S1). The joint test was per-
formed following an approach similar to the model pro-
posed by Korn et al. [24]. That is, at any particular locus
containing SNP alleles labeled generically as A and B:
Ya b a b =+ − () ++ () +    12 (1)
where Y represents the dependent variable of interest, a is
the number of A alleles at the locus, b is the number of B
alleles at the locus, b1 corresponds to the additive SNP
allele effect, and b2 corresponds to the additive copy num-
ber effect. The joint test involves assessing the null hypoth-
esis: b1 = b2 = 0. When either SNP allele or copy number
state is invariant, the model defaults to a single test of either
allelic or copy number effect: b1 =0o rb2 = 0, respectively.
The model described in equation {1} can be manipu-
lated to give investigators control over potential con-
founding factors by including them as covariates.
Because the HyperGEN cohort includes family data, the
model was altered into a mixed model by including ran-
dom effects for each family. Furthermore, population
stratification due to genetic admixture can confound
population association studies or produce spurious
results [29-32]. To account for this problem, the first
four principal components were included in the model
as fixed effects covariates [33]. The choice of four prin-
cipal components was based on examination of the asso-
ciated eigenvalues (Additional file 2, Table S1). Finally,
age, age-squared, sex, and the recruitment center were
included as additional fixed effects covariates. Thus, the
full mixed model used for the analysis can be written as:
ln AR2D a b a b
PC Age
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2
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where, in addition to the parameters described in {1},
jj, j = 1,...,4 are the fixed effects from the first four prin-
cipal components, j5, j6, j7, j8 and are the fixed effects
for age, age-squared, sex, and recruitment center,
respectively, and gi is the family random effect of the i
th
subject.
Fitting the mixed model described in equation {2} for
each SNP marker locus is currently infeasible without
approximations [34]. Because of this limitation, a two-
stage procedure was enacted. In the first stage, a test of
association using the GRAMMAR approach introduced
by Aulchenko et al. [35] was used to determine the
1,000 most-likely significant markers. In the second
stage, those 1,000 markers, referred to as the top 1,000,
were tested using the full mixed model described in
equation {2}. The GRAMMAR approach allows genome-
wide mixed model calculations to be computed on a
reasonable timescale. As part of the procedure, model
residuals for aortic root diameter measurements are
generated via mixed model after controlling for related-
ness and fixed effect covariates. However, genetic effects
are not included. In terms of the present study:
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(3)
The resulting residuals ( Yi
*)f o rt h ei
th subject are
then regressed against his or her SNP allele and copy
number state at each locus in a linear model:
Ya b a b
* =+ − () ++ () +    12. (4)
Residuals for use in the GRAMMAR approach were
obtained from the PROC MIXED procedure in SAS
®
software, Version 9.1.2 (SAS Institute Inc., Cary, NC).
The residuals were regressed on allelic and copy number
state via lm using R version 2.10.1 [36]. Genome-wide
measurements were recorded (Figure 1). The markers
corresponding to the 1,000 most-likely significant find-
ings using this approach were recorded; and only these
were analyzed in the full mixed model described in
equation {2}, using the lmer function in R [37]. The
most promising results are included in Table 3 and the
second stage results from all loci in the top 1,000 are
included in Additional file 3, Table S2. Genetic markers
with p-values less than 5 × 10
-7 were defined as gen-
ome-wide significant [12,17].
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Genome-wide results were generated via a two-stage
procedure (see Methods). The GRAMMAR procedure
(first stage), alone, does not provide accurate parameter
estimates and significance values. The systematic
depression of the test statistic, which can be seen in
the quantile-quantile (QQ) plot (Additional file 4,
Figure S1), demonstrates that this method is inherently
Figure 1 Genome-wide results from the GRAMMAR procedure (first stage). Chromosomes are separated by color.
Table 3 The top ten most significant markers from the first and second stages of the aortic root diameter genome-
wide association study
Stage 1 Stage 2
Chromosome Base pair Marker MAF p-value SNP effect* p-value Gene(s)
3 59,877,841 rs1825630 0.444 3.70 × 10
-5 9.46 (2.11) 7.99 × 10
-6 FHIT
7 65,255,030 rs875971 0.324 3.99 × 10
-5 10.69 (2.24) 4.09 × 10
-6 CRCP
7 65,668,047 rs801193 0.337 3.97 × 10
-5 11.13 (2.23) 3.65 × 10
-6 LOC401365, LOC493754
7 65,700,370 rs10258739 0.318 2.11 × 10
-5 10.64 (2.26) 2.50 × 10
-6
7 65,733,463 AFFX 9317457 0.332 6.24 × 10
-6 11.25 (2.23) 6.20 × 10
-7 KCTD7, RABGEF1
7 65,733,463 rs10263935 0.324 9.06 × 10
-6 11.42 (2.28) 4.26 × 10
-7 KCTD7, RABGEF1
7 65,790,536 rs2659915 0.334 4.10 × 10
-5 10.84 (2.22) 4.27 × 10
-6 RABGEF1
8 117,625,451 rs4876662 0.195 2.70 × 10
-5 13.17 (2.58) 2.23 × 10
-6
16 57,316,833 rs12600277 0.162 2.84 × 10
-5 13.99 (2.98) 2.72 × 10
-6 GOT2
20 1,888,504 rs6045666 0.351 3.21 × 10
-5 12.58 (2.26) 2.97 × 10
-6 SIRPA, PDYN†
20 1,889,171 rs6045676 0.356 5.31 × 10
-7 11.47 (2.28) 3.28 × 10
-8 SIRPA, PDYN†
The markers at rs6045676 and rs10263935 reach the threshold for genome-wide significance (p < 5 × 10
-7). The last column lists known genes and proteins of
unknown function within 10 kb of the identified marker.
* The regression coefficients (10
-2 scale) for the SNP effect in equation {2} and its standard error (in parentheses) are included. Meanwhile, CNV effects are
excluded due to the low observed CNV frequency at each marker (<1%).
† These genes are outside the 10 kb restriction, yet still included.
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[35]. Due to this limitation we implemented the GRAM-
MAR approach as a screening procedure. In this first
stage, the top 1,000 loci were identified. These loci
included all markers with p-values less than 2.5 × 10
-3.
In general, these markers appeared to be uniform across
the genome, with the exception of a few regions. Chro-
mosome 7, in particular, had numerous markers making
it into the top 1,000. Many of these markers were found
in a 500 kb region spanning the CRCP and KCTD7
genes. It should be noted that neither loci within genes
previously found to be associated with thoracic aortic
aneurysm (ACTA2, MYH11, TGFBR1,a n dTGFBR2),
nor regions previously identified as being associated
with aortic root size reached inclusion into the top
1,000 [17].
As the results from the GRAMMAR procedure, alone,
are not conclusive, we re-analyzed the top 1,000 from
the first stage using the full mixed model described in
equation {2}. We identified two regions of significance:
the strongest signal found between the SIRPA and
PDYN genes on chromosome 20; and numerous signals
within the 500 kb region on chromosome 7 highlighted
in the first stage results. In total there were 24 marker
loci with p-values less than 1 × 10
-5.M a n yo ft h e s e
w e r el o c a t e dw i t h i nt h e5 0 0k br e g i o no nc h r o m o s o m e
7 (Figure 2), but a few were found elsewhere (Table 3).
While the loci that reached or approached genome-
wide significance predominantly achieved that thresh-
old based upon SNP effects, the second largest signal,
found within the KCTD7 gene on chromosome 7, was
influenced, in part, by a rare copy number variant (less
than 1%). The copy number estimate at this locus was
nearly three times its standard error. Also, a 40 kb
copy number variable region on chromosome 2 within
ag e n eg a pb e t w e e nLPIN1 and TRIB2 genes showed
relatively large copy number effect estimates - about
four times its standard error. At this location, a rare
deletion was correlated with higher aortic root dia-
meter (pCNV =2 . 9 7×1 0
-5).
Figure 2 Inspection of significance peak on chromosome 7. Linkage disequilibrium measurements (below) overlaid with results from the full
mixed model (second stage) on chromosome 7: 64,902,615 - 65,866,167 (above).
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African Americans have been disproportionately repre-
sented in genetic association studies on cardiovascular
traits despite a well-documented high burden of cardio-
vascular diseases. We implemented a non-traditional
statistical approach to test for genetic associations with
aortic root diameter in African American family mem-
bers enrolled in the HyperGEN study. This method
allowed us to jointly test for SNP and CNV effect while
controlling for family structure.
We identified two novel regions of genetic association
on chromosomes 7 and 20. The significant SNPs in
each region (rs10263935 and rs6045676, respectively)
have different allele frequencies in YRI and CEU popula-
tions in HapMap [38] - providing a possible explanation
why these associations have not been observed in pre-
vious studies based on populations of European descent
[17]. The single strongest signal of genetic association
was found on chromosome 20 between the SIRPA and
PDYN genes. However, a clear relationship with either
gene to cardiovascular traits beyond the results of this
study has not been discovered. SIRPA is involved in
negative regulation with numerous growth factor signal-
ing receptors; and PDYN has been found to be asso-
ciated with nonlesional temporal lobe epilepsy [39], but
results have not been replicated [40]. Meanwhile, the
much wider region identified on chromosome 7 con-
tains an interesting gene that has been previously found
to be related to cardiovascular outcomes: CRCP.T h e
product of the CRCP gene is known to interact with
CRLR to facilitate adrenomedullin (ADM) mediated sig-
naling [41]. CRLR has been found to be significantly
decreased in the umbilical artery and uterus of women
with pregnancy-induced hypertension [42]. Also, post-
translationally modified ADM has been known to influ-
ence vasodilation [43].
The two-stage procedure, joint analysis, and ascertain-
ment scheme offered some limitations to the present
study. First, it is possible that we missed a true associa-
tion that did not pass the first stage criteria; but after
comparing the results between the loci that were
included in both steps, we are fairly comfortable as the
results were consistent across stages. Only three of the
top 1,000 did not have p-values less than 3 × 10
-3 in the
second stage; and among the most significant findings,
nine were in the top ten most significant findings in
both stages. Second, the joint analyses we performed
frequently reverted back to a conventional SNP analysis
due to the majority of the genome being copy number
invariant. However, we were cautious about using a
SNP-only approach throughout the genome as it would
require us to either treat non-two-copy genotypes
as missing, or force them into a two-copy state.
And finally, the HyperGEN sib-pair ascertainment
scheme restricted our ability to distinguish inherited
copy number variation from variants arisen through de
novo mutation as the direct transmission of CNVs from
both parents to offspring was unobservable.
We found no findings that proved copy number varia-
tion was playing a role in the pathogenesis of aortic root
diameter, but we do not believe CNVs should be ruled
out altogether. In a few cases we found large estimates
with promising significance values. Unfortunately, the
low frequency of copy number events restricted our
ability to separate their effects from more frequent
SNPs. Also, copy number variants potentially cover
numerous loci. In terms of copy number alone, we
expect perfect or near-perfect linkage disequilibrium
among those loci. Therefore, perhaps the same criteria
imposed for genome-wide significance on SNPs should
not hold for CNVs when looking at a “per locus” level.
Among those genes we identified as potentially influ-
encing aortic root diameter, CRCP perhaps shows the
most promise. However, the large region encompassing
this gene shows strong patterns of linkage disequili-
brium (Figure 2). Numerous other neighboring genes or
loci could be influencing the result. Our other primary
finding on chromosome 20 is curious as the flanking
genes and reported expression results have not pre-
viously identified this region as contributing to cardio-
vascular outcomes. Nonetheless, future genetic studies
on aortic root diameter and other related cardiovascular
traits should consider the regions we identified as
candidates.
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